BREAKING…The Ninth Circuit Court of Appeals is the first Appellate court to be presented with the question of whether the Pfizer-BioNtech COVID-19 drug was actually what the FDA stated in its official notice that it was—investigational, not FDA-approved. This matters because your right to refuse unwanted investigational medical treatment is a fundamental right that cannot be penalized when refusing. The con of interchangeability is now getting a front-row seat at America's federal judiciary, where Appellate courts cannot make incredulous claims on a subject impacting the whole of the nation and a $600b pharmaceutical industry.
Next Up? The Fifth and Tenth Circuits answer the same question.
….
The brief is below:
https://covidpenalty.com/wp-content/uploads/2024/07/Doc-27.1-Curtis-Ninth-Brief.pdf
https://x.com/GodsRiddles/status/1813337998312006098
https://www.imdb.com/title/tt0764042/?ref_=ttep_ep4